Westerville, OH, United States of America

Brian K Kaspar

This inventor holds 29 USPTO granted patents and 37 published patent applications, plus 6 CIPO patents and 7 EPO patents, primarily in Gene Delivery Technology. Top assignees: Nationwide Children's Hospital, The Ohio State University, University of California. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian K Kaspar. Retrieved from https://idiyas.com/inventor/brian-k-kaspar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 37)

% Patents Active = 96.6

CIPO Patents = 6 (Patent Applications = 16)

EPO Patents = 7 (Patent Applications = 19)

Average Co-Inventor Count = 2.3

ph-index = 8

Forward Citations = 277(Granted Patents)

Location History:

San Diego, CA (US) (2006 - 2019)
New Albany, OH (US) (2017 - 2019)
Columbus, OH (US) (2010 - 2020)
Westerville, OH (US) (2014 - 2024)

Company Filing History:

20 out of 179

Nationwide Children's Hospital

patents

10 out of 1,584

The Ohio State University

patents

4 out of 16,035

University of California

Integrative Gene Therapeutics

patent

7. 1 out of 530

Ludwig Institute for Cancer Research Limited

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Adeno-Associated Virus

Gene Delivery

Recombinant Viruses

Drug Potency Assays

Amyotrophic Lateral Sclerosis

Polynucleotide Delivery

Mutant Virions

Targeted Gene Transfer

Myostatin Inhibition

Eukaryotic Microalgae

NF-kB Inhibition

Methyl-CpG Binding Protein

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404523 - Adeno-associated virus delivery of CLN3 polynucleotide (2025-09-02),

2. 12357663 - Intrathecal delivery of recombinant adeno-associated virus encoding methyl-CpG binding protein 2 (2025-07-15),

3. 12228571 - Cell-based assay for measuring drug product potency (2025-02-18),

4. 12208144 - Intrathecal delivery of recombinant adeno-associated virus 9 (2025-01-28),

5. 12168777 - Means and method for producing and purifying viral vectors (2024-12-17),

6. 12077748 - Methods and materials for producing recombinant viruses in eukaryotic microalgae (2024-09-03),

7. 11738094 - Intrathecal delivery of recombinant adeno-associated virus 9 (2023-08-29),

8. 11730829 - Intrathecal delivery of recombinant adeno-associated virus 9 (2023-08-22),

9. 11583564 - Intrathecal delivery of recombinant adeno-associated virus encoding Methyl-CpG binding protein 2 (2023-02-21),

10. 11413357 - Intrathecal delivery of recombinant adeno-associated virus 9 (2022-08-16),

11. 11311634 - Intrathecal delivery of recombinant Adeno-associated virus 9 (2022-04-26),

12. 11219696 - Delivery of polynucleotides using recombinant AAV9 (2022-01-11),

13. 11040116 - Intrathecal delivery of recombinant adeno-associated virus 9 (2021-06-22),

14. 10907130 - Methods and materials for producing recombinant viruses in eukaryotic microalgae (2021-02-02),

15. 10842886 - Guided injections for AAV gene transfer to muscle (2020-11-24),

Title: The Innovative Journey of Brian K Kaspar

Introduction:

Brian K Kaspar, a talented inventor hailing from Westerville, Ohio, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Brian K Kaspar's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights:

With over two decades of experience in research and development, Brian K Kaspar has a proven track record of turning innovative ideas into practical solutions. His work has been instrumental in shaping the future of various industries.

Collaborations:

Throughout his career, Brian K Kaspar has collaborated with leading research institutions, top universities, and renowned companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been key to his success.

Conclusion:

In conclusion, Brian K Kaspar's passion for innovation, coupled with his dedication to pushing the boundaries of technology, has established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.